课题基金 / 基金详情

CLINICAL TRIAL: TRIAL OF BETA BLOCKER THERAPY (ATENOLOL) VS ANGIOTENSIN II RECE

CLINICAL TRIAL: TRIAL OF BETA BLOCKER THERAPY (ATENOLOL) VS ANGIOTENSIN II RECE
临床试验：β 受体阻滞剂治疗（阿替洛尔）对比血管紧张素 II RECE 的试验
批准号：
8174439
负责人：
DAVID L RIMOIN
金额：
$0.92万
依托单位：
LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
2009
资助国家：
美国
项目状态：
已结题
起止时间：
2009-12-01 至 2010-11-30
来源：
https://reporter.nih.gov/project-details/8174439
关键词：
Adrenergic beta-AntagonistsAngiotensin ReceptorAngiotensinsAortic Valve InsufficiencyAtenololClinical TrialsClinical Trials DesignComputer Retrieval of Information on Scientific Projects DatabaseFundingGrantGrowthIndividualInstitutionMarfan SyndromePatientsPhaseRandomizedResearchResearch PersonnelResourcesSourceUnited States National Institutes of Health

项目摘要

项目成果

DAVID L RIMOIN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This is a Phase III, randomized, multi-center trial designed to compare the effect of beta-blocker therapy to that of angiotensin receptor blocker therapy on rate of change in aortic growth and progression of aortic regurgitation in individuals with Marfan Syndrome. Patients are followed for three years after randomization.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
THE INTERNATIONAL SKELETAL DYSPLASIA REGISTRY
  • 批准号：
    8125466
  • 项目类别：
  • 资助金额：
    $20.91万
  • 财政年份：
    2010
  • 负责人：
    DAVID L RIMOIN
  • 依托单位：
    CEDARS-SINAI MEDICAL CENTER
The Skeletal Dysplasias
  • 批准号：
    7931042
  • 项目类别：
  • 资助金额：
    $5.06万
  • 财政年份：
    2009
  • 负责人：
    DAVID L RIMOIN
  • 依托单位：
    CEDARS-SINAI MEDICAL CENTER
CLINICAL TRIAL: MUSCULOSKELETAL PHENOTYPE OF MARFAN PATIENTS
THE SKELETAL DYSPLASIA REGISTRY - GENETICS AND THE PATHOGENESIS
海外基金